Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
198 studies found for:    Restless Legs Syndrome
Show Display Options
RSS Create an RSS feed from your search for:
Restless Legs Syndrome
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed
Has Results
Non-interventional Study (NIS) in Patients With Restless Legs Syndrome in Daily Practise
Condition: Idiopathic Restless Legs Syndrome
Intervention: Drug: Neupro®
2 Completed
Has Results
Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: ropinirole controlled release (CR)-RLS
3 Terminated Safety and Efficacy of Rasagiline in Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: rasagiline;   Drug: placebo (sugar pill)
4 Active, not recruiting Cranial Electrotherapy for Military Beneficiaries With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Device: Active CES Device Alpha-Stim®;   Device: Sham Device
5 Terminated Blinded, Randomized Study of Gabapentin (Neurontin®) and Gabapentin Enacarbil (Horizant™) in Restless Leg Syndrome
Condition: Restless Leg Syndrome
Interventions: Drug: Gabapentin immediate release;   Drug: Gabapentin enacarbil extended release
6 Completed
Has Results
Long Term Study Of Pregabalin In Idiopathic Restless Legs Syndrome Patients
Condition: Idiopathic Restless Legs Syndrome
Interventions: Drug: placebo and pregabalin;   Drug: pramipexol;   Drug: Pregabalin
7 Completed 12-week Polysomnography Study of Ropinirole Controlled Release for Restless Legs Syndrome
Conditions: Restless Legs Syndrome (RLS);   Restless Legs Syndrome
Intervention: Drug: ropinirole CR-RLS
8 Completed RESTIFFIC™ Foot Wrap Reduces Moderate to Severe Restless Leg Syndrome
Condition: Restless Leg Syndrome
Intervention: Device: RESTIFFIC™ Brand Pressure Application System
9 Completed Altered Brain GABA and Glutamate in Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention:
10 Completed Converting From Ropinirole Immediate Release (IR) To Ropinirole Controlled-Release for RLS (Restless Legs Syndrome)
Conditions: Restless Legs Syndrome;   Restless Legs Syndrome (RLS)
Intervention: Drug: ropinirole controlled-release for RLS
11 Active, not recruiting Glutamate, Hyperarousal and Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention:
12 Completed
Has Results
Botulinum Toxin to Treat Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: Botulinum Toxin A
13 Completed
Has Results
Bupropion and Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: Bupropion;   Drug: Placebo
14 Unknown  Neuroma Injections to Treat Restless Legs Syndrome - RCT
Condition: Restless Legs Syndrome
Interventions: Drug: equal parts of 0.5% plain Marcaine and 2% lidocaine mixed with 0.8 mg Depo-medrol/4% absolute alcohol in a total injection volume of 1 ml;   Drug: Normal saline - 1ml
15 Recruiting A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome
Condition: Restless Legs Syndrome
Interventions: Device: MMF07 Foot Massager;   Device: Heat Therapy
16 Completed ASP8825 - Study in Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Interventions: Drug: ASP8825;   Drug: Placebo
17 Completed Restless Legs Syndrome Treatment With Botulinum Toxin
Condition: Restless Legs Syndrome
Intervention: Drug: BNT (intradermal injection)
18 Terminated Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention: Drug: aplindore MR tablets or Placebo
19 Completed
Has Results
Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome
Condition: Restless Legs Syndrome
Intervention:
20 Completed Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS)
Condition: Restless Legs Syndrome
Interventions: Drug: IPX159;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.